

RFK Jr.'s vaccine advisers meeting wraps up
6 snips Jun 27, 2025
A panel of vaccine advisers, selected by Robert F. Kennedy Jr., wrapped up a two-day meeting with contentious discussions about flu vaccines. They voted to limit certain vaccines, citing concerns over a controversial preservative despite evidence of its safety. The chaotic nature of the meeting has raised eyebrows and sparked debate among healthcare professionals about vaccine safety and access. The implications of their decisions echo throughout the public health landscape.
AI Snips
Chapters
Transcript
Episode notes
Controversy in Vaccine Advisory Panel
- Robert F. Kennedy Jr. replaced the entire vaccine advisory panel with handpicked members, some known for spreading COVID vaccine misinformation.
- This has made the advisory committee unusually high profile and controversial.
Revisiting Vaccine Safety
- The new committee plans to reevaluate the childhood vaccine schedule and review vaccines not assessed in over seven years.
- This signals a revisit of vaccine safety questions that had been previously settled.
Risks of Reopening Vaccine Safety Debates
- Experts worry the committee is reopening settled debates on vaccine safety, an issue that critics have long exploited.
- This could undermine public trust in vaccines and policy stability.